Market Newsdesk

April 14, 2026 4:16 pm

New Era Energy & Digital Secures Funding for Development of its Ector County, Texas Data Center Campus, Including Exercise of Underwriters’ Option

Closing of the full exercise of $15 million underwriters’ option brings New Era a total of $115 million in equity funding pursuant to the previously announced public offering, the initial Macquarie credit facility provides funding of $20 million with potential future availability of an additional $270 million for TCDC development, and an additional $5 million in funding was provided via an equity investment from Macquarie

MIDLAND, Texas, April 14, 2026 (GLOBE NEWSWIRE) — New Era Energy & Digital, Inc. (NASDAQ: NUAI) (“New Era” or the “Company”), a developer and operator of next-generation digital infrastructure and integrated power assets in the Permian Basin, today announced the closing of the underwriters’ option to purchase additional shares of common stock in connection with the Company’s previously announced public offering (the “Equity Offering”), resulting in total gross proceeds of approximately $115 million, together with the initial funding of the $20 million first tranche loan under the previously announced $290 million senior secured term loan credit facility (“Term Loan”) with Macquarie Group’s Commodities and Global Markets business (“Macquarie”), as well as an additional $5 million equity investment from Macquarie at approximately $5 per share.

This balance sheet transformation marks a deliberate step toward execution and a significantly strengthened financial position, with combined equity proceeds and committed project-level financing providing a clear capital pathway to progress the development of the Company’s flagship project, Texas Critical Data Centers LLC (“TCDC”).

The Term Loan is expected to be used to support key commercial and development milestones, including the procurement of key long-lead equipment and ongoing site development. The Company intends to use the proceeds from the public offering to repay all outstanding borrowings under its senior secured convertible promissory note with SharonAI Holdings Inc. and the remainder for general corporate purposes. Upon repayment of the SharonAI note, the Company will eliminate SharonAI’s existing liens and simplify its capital structure, enhancing its ability to execute financing initiatives and advance commercial discussions with key counterparties.

New Era’s financing initiatives are complemented by its previously announced non-binding letter of intent with Stream Data Centers, a leading U.S. data center development and operating platform. Together with Macquarie, a global financial services group, these relationships reflect growing institutional alignment across the Company’s capital stack and development platform.

“This marks a pivotal milestone for New Era,” said E. Will Gray II, Chief Executive Officer of New Era. “With these transformative financings, we have secured the capital required to support TCDC’s development beyond just phase 1, and significantly strengthened our balance sheet. Our credit facility with such a trusted expert in infrastructure like Macquarie provides us with valuable financial flexibility as we invest in multiple phases of TCDC development. We remain fully focused on advancing TCDC toward commercialization and executing on the significant demand we are seeing for next-generation AI infrastructure.”

Joshua Stevens, Managing Director at Macquarie, added “We are pleased to support New Era in the development of their TCDC project. We believe TCDC is strategically positioned for near-term development and power delivery, presenting a compelling opportunity to address the growing demand for high-performance computing infrastructure.”

Northland Capital Markets served as the lead book-running manager for the Equity Offering and capital markets advisor to the Company for the Term Loan. Texas Capital Securities served as book-running manager for the Equity Offering.

About New Era Energy & Digital, Inc.

New Era is a developer and operator of next-generation digital infrastructure and integrated power assets. The Company is developing Texas Critical Data Centers LLC (“TCDC”), a 438 acre large-scale AI and high-performance computing data center campus located in Ector County, outside Odessa, Texas. TCDC is master planned as a multi-phase development, with anticipated capacity scaling to 1+ gigawatt over time. With a growing portfolio of strategically located, vertically integrated resources including powered land and powered shells, the Company delivers turnkey solutions that enable hyperscale, enterprise, and edge operators to accelerate data center deployment, optimize total cost of ownership, and future-proof their infrastructure investments.

For more information, visit: www.newerainfra.ai and follow New Era Energy & Digital on LinkedIn and X.

For investor inquiries, please contact:

OG Advisory Group
Lincoln Tan
[email protected]

Forward-Looking Statements

This press release contains “forward-looking statements.” Forward-looking statements reflect the current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the offering and the use of proceeds therefrom. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, the risks contained in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

April 14, 2026 4:15 pm

First Internet Bancorp to Announce First Quarter 2026 Financial Results on Thursday, April 30

First Internet Bancorp to Announce First Quarter 2026 Financial Results on Thursday, April 30

Conference call and webcast to be held at 5:00 p.m. on Thursday, April 30

FISHERS, Ind.–(BUSINESS WIRE)–
First Internet Bancorp (the “Company”) (Nasdaq: INBK), the parent company of First Internet Bank (www.firstib.com), announced today that it will host a conference call and webcast to review first quarter 2026 financial results on Thursday, April 30 at 5:00 p.m. Eastern Time. The financial results are scheduled to be released after the market closes on Thursday, April 30.

Conference Call and Webcast Information:
Date and Time:	Thursday, April 30, 5:00 p.m. Eastern Time

Telephone Access:	1-800-715-9871 (U.S. toll free) 1-646-307-1963 (Toll)
Telephone Replay:	1-800-770-2030 (U.S. toll free) 1-647-362-9199 (Toll) Conference ID: 9553116 The conference call replay will be available one hour after the live call has ended and available through May 7, 2026.

Webcast and Presentation Slides:	To access the webcast and view the presentation slides, please visit http://www.firstinternetbancorp.com and click the link provided for Earnings Call Webcast. The webcast and slides will be available on the Company’s website shortly after the call has ended and will be archived on the Company’s website for 12 months.

About First Internet Bancorp

First Internet Bancorp is a bank holding company with assets of $5.6 billion as of December 31, 2025. The Company’s subsidiary, First Internet Bank, opened for business in 1999 as an industry pioneer in the branchless delivery of banking services. First Internet Bank provides consumer and small business deposit, SBA financing, franchise finance, consumer loans, and specialty finance services nationally as well as commercial real estate loans, construction loans, commercial and industrial loans, and treasury management services on a regional basis. First Internet Bancorp’s common stock trades on the Nasdaq Global Select Market under the symbol “INBK” and is a component of the Russell 2000® Index. Additional information about the Company is available at www.firstinternetbancorp.com and additional information about First Internet Bank, including its products and services, is available at www.firstib.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260414210372/en/

Investors/Analysts

Paula Deemer

Director of Corporate Administration

(317) 428-4628

[email protected]

Media

PANBlast

Zach Weismiller

[email protected]

KEYWORDS: Indiana United States North America

INDUSTRY KEYWORDS: Professional Services Small Business Other Professional Services Finance Asset Management Banking

MEDIA:

Logo

April 14, 2026 4:14 pm

Gloo Holdings, Inc. Reports Fourth Quarter and Fiscal 2025 Financial Results

Gloo Holdings, Inc. Reports Fourth Quarter and Fiscal 2025 Financial Results

Achieves Q4 2025 Revenue of $33.6 million, exceeding guidance and analyst consensus

Raises fiscal year 2026 Revenue guidance to $190 million

Expects more than 30% sequential improvement in Adjusted EBITDA from Q4 25 to Q1 26

Accelerates progress toward Adjusted EBITDA profitability

BOULDER, Colo.–(BUSINESS WIRE)–
Gloo Holdings, Inc. (Nasdaq: GLOO), a leading technology platform for the faith and flourishing ecosystem, today announced financial results for the quarter and year ended January 31, 2026. The company reaffirmed first quarter guidance and Adjusted EBITDA guidance and raised fiscal year 2026 revenue guidance to $190 million.

“We closed fiscal 2025 with a strong quarter that exceeded both our revenue guidance and analyst expectations. These results are particularly meaningful as they reflect our progress towards Adjusted EBITDA profitability and how AI is accelerating our momentum,” said Scott Beck, CEO of Gloo. “AI can unlock enormous possibilities for ministries, network capability providers and churches to grow their reach and impact, but only if they have access to the right tools. We believe that our focus on applied AI and bringing agentic workflows to the faith and flourishing sector uniquely positions us to capture that opportunity, while advancing our purpose of serving those who serve.”

Fourth Quarter and Fiscal 2025 Financial Highlights

Raised proceeds of $72.3 million, net of underwriting fees and discounts, in conjunction with the company’s initial public offering (IPO), completed in the fourth quarter of 2025. Additionally, converted $143.1 million of debt and related accrued interest amounts to equity in conjunction with the company’s IPO, significantly strengthening the company’s balance sheet.
Total revenue for the fourth quarter was $33.6 million, representing 418% growth, compared to the prior year period, beating quarterly consensus of $31.6 million. Total revenue for fiscal 2025 was $94.7 million, representing 308% growth compared to fiscal 2024.
- Platform revenue for the fourth quarter and fiscal 2025 totaled $20.1 million and $57.2 million, up 219% and 150%, respectively, compared to the prior year periods.
- Platform solutions revenue for the fourth quarter and fiscal 2025 totaled $13.5 million and $37.5 million, up $13.3 million and $37.1 million, respectively, compared to prior year periods.
Net loss of $48.6 million and $158.7 million, for the fourth quarter and fiscal 2025, respectively. This compares to net loss of $44.8 million and $85.8 million for the fourth quarter and fiscal 2024, respectively.
- There were meaningful non-cash charges in the fourth quarter. Adjusting for these, non-GAAP net loss attributable to stockholders of Gloo Holdings, Inc. was $39.4 million for the fourth quarter of 2025. This compares to non-GAAP net loss attributable to members of Gloo Holdings, LLC of $50.4 million for the fourth quarter of 2024.
Adjusted EBITDA was negative $18.6 million for the fourth quarter, beating consensus estimates of negative $18.7 million. This is on the better end of the company’s guidance range of negative $19.0 million to negative $18.5 million.

“Last quarter, we said we expected to end 2025 on a positive note, and our results confirm exactly that, reflecting strong execution and financial discipline. We achieved impressive year-over-year growth, and Q4 2025 revenue that exceeded both our guidance and analyst consensus, and Adjusted EBITDA at the better end of our range,” said Paul Seamon, CFO of Gloo. “Looking ahead, our Q1 2026 guidance and sequential improvement in Adjusted EBITDA keeps us firmly on track for delivering Adjusted EBITDA profitability by Q4 2026.”

Business Highlights

Advancing Leadership in Applied AI

Gloo is advancing leadership in applied AI by leveraging the latest innovations in agentic AI, foundational models and services from top AI companies, combining them with Gloo platform capabilities. As part of this strategy, Gloo takes on and modernizes customer technology and operations, applying agentic AI to deliver better outcomes at lower cost for customers, with strong margins and highly durable revenue streams for Gloo.

As co-host of the Missional AI Conference, previewed two new projects, including a faith-based adversarial evaluator as part of its FAI Initiative and a Language Integration Protocol (LIP) project to standardize AI training in new languages.
Published the peer-reviewed Flourishing AI Christian (FAIC) Benchmark report, outlining the methodology and research behind how AI outputs measure to a Christian worldview.
Launched Gloo AI Studio in March, providing a production-grade AI development platform to faith-based and mission-driven developers.

Strategic Acquisitions

The company continues to execute on its strategic acquisition strategy, further increasing the value and reach of the Gloo platform.

Announced a definitive agreement to acquire Enterprisemarketdesk (EMD), an established Workday Services Partner that provides consulting, implementation and support services to nonprofit, small and mid-market organizations. This expands Gloo’s enterprise technology capabilities and strengthens the Gloo 360 value proposition as the technology infrastructure management service of choice for the faith and flourishing ecosystem.
Successful completion of Westfall Group acquisition, a leading platform for major donor engagement in the faith and flourishing ecosystem, expanding Gloo’s capabilities in donor development and strengthening synergies with Masterworks, which was acquired in 2025.

Customer Momentum

Gloo continued to close deals in the fourth quarter of fiscal 2025 at over $1 million in annual contract value. Key examples include new agreements with InterVarsity and Jessup University.

Announced new strategic technology partnership with InterVarsity Christian Fellowship/USA, deploying Gloo 360 to power their enterprise technology operations. This enables InterVarsity to spend less time managing systems and more time engaging students and faculty across 700+ U.S. campuses.
Partnered with Jessup University to modernize its operational and technology foundation, creating the capacity to invest directly in student success initiatives while strengthening marketing, enrollment growth, and retention outcomes.
We also expanded our partnership with YouVersion in Brazil, establishing a co-located engineering presence alongside their Regional Hub to strengthen cultural alignment with their team while building engineering capacity in the region.

Fiscal Year 2026 Outlook

Gloo is reaffirming revenue guidance for its first quarter to be $36 million, which represents a nearly tripling of revenue growth over the prior year period. For fiscal year 2026, Gloo is raising guidance to $190 million, which represents a more than doubling over the prior year period. Adjusted EBITDA is expected to be negative $12 million for the first quarter of 2026 which is more than 30% sequential improvement in Adjusted EBITDA from Q4 25 to Q1 26. The company continues to expect to approach Adjusted EBITDA breakeven in third quarter 2026, and remains confident in achieving Adjusted EBITDA profitability in fourth quarter 2026.

Gloo has not provided a reconciliation of its forward outlook for Adjusted EBITDA to its most directly comparable GAAP financial measure in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Gloo is unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate this non-GAAP financial measure, particularly related to interest expense and changes in fair value of certain financial instruments, as well as equity-based compensation and employee stock transactions and related tax effects.

Conference Call Information

Gloo will conduct a conference call with analysts and investors to discuss its fourth quarter and fiscal 2025 financial results and current financial prospects today at 5 p.m. ET. Participants may access the conference call via webcast using the Gloo Webcast link. The webcast will be recorded and available for replay. The link and recording will also be available on the Investor Relations section of the Gloo website at investors.gloo.com.

About Gloo

Gloo (Nasdaq: GLOO) is a leading technology platform serving the faith and flourishing ecosystem. Gloo helps missional organizations amplify their impact by powering their technology and expanding their reach, so that people flourish and organizations thrive. The company’s values-aligned AI platform modernizes systems, workflows and data, while its marketing and donor solutions expand reach, awareness and long-term giving for mission-based organizations. Based in Boulder, Colorado, Gloo serves over 140,000 faith, ministry, and nonprofit leaders.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical or current fact included in this press release are forward-looking statements, including but not limited to statements regarding our growth prospects, our ability to achieve Adjusted EBITDA profitability, the impact of AI on the faith and flourishing sector and on our business and growth prospects, market share gains, our acquisition strategy and business initiatives, and our outlook for the fourth quarter and fiscal year of 2025. Forward-looking statements include statements containing words such as “expect,” “anticipate,” “believe,” “project,” “will” and similar expressions intended to identify forward-looking statements. These forward-looking statements are based on our current expectations. Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors. Some of these risks are described in greater detail in our Prospectus dated November 18, 2025, filed with the Securities and Exchange Commission (the “SEC”) on November 19, 2025, and in the other documents we file with the SEC from time to time, including our Quarterly Report on Form 10-Q for the quarter ended October 31, 2025, filed with the SEC on December 23, 2025, and our annual report on Form 10-K, which we expect to file with the SEC on or around the date of this press release. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements we may make. These factors may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our forward-looking statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not rely on these statements or regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified timeframe, or at all. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Non-GAAP Financial Measures

To supplement its condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), Gloo has provided in this press release and the accompanying tables the following non-GAAP financial measures: Adjusted EBITDA, non-GAAP net loss attributable to stockholders and members of Gloo Holdings, Inc. and Gloo Holdings, LLC, respectively, and non-GAAP net loss per unit attributable to common stockholders of Gloo Holdings, Inc. (Class A and Class B) and members of Gloo Holdings, LLC, basic and diluted.

Gloo uses Adjusted EBITDA to evaluate its core operating performance, support planning and forecasting, and assess strategic opportunities. In addition, Gloo may use Adjusted EBITDA in its incentive compensation programs applicable to some of its employees. Accordingly, Gloo believes that Adjusted EBITDA may provide useful information to investors about its business and financial performance, enhance its overall understanding of our past performance and future prospects, and allow for greater transparency with respect to this measure used by Gloo management in their financial and operational decision making.

Adjusted EBITDA is defined as net loss adjusted to exclude (1) interest expense, (2) income tax expense (benefit), (3) depreciation and amortization, (4) equity-based compensation, (5) impairment of goodwill, (6) loss (gain) from change in fair value of financial instruments, (7) restructuring costs, (8) transaction related bonuses, (9) loss on extinguishment of debt, (10) income (loss) from equity method investments, net, (11) interest income, (12) IPO-related costs, and (13) one-time employee tax credit, that are not reflective of Gloo’s core operating results.

Gloo also presents non-GAAP net loss attributable to stockholders and members of Gloo Holdings, Inc. and Gloo Holdings, LLC, respectively, and non-GAAP net loss per unit attributable to common stockholders of Gloo Holdings, Inc. (Class A and Class B) and members of Gloo Holdings, LLC, because it believes that these measures may similarly provide useful information to investors about its business and financial performance, enhance its overall understanding of our past performance and future prospects, and allow for greater transparency with respect to this measure used by Gloo management in their financial and operational decision making. Management also believes that these measures are commonly used by securities analysts, investors and other interested parties in the evaluation of the Company’s performance.

Non-GAAP net loss attributable to stockholders and members of Gloo Holdings, Inc. and Gloo Holdings, LLC, respectively, and non-GAAP net loss per unit attributable to common stockholders of Gloo Holdings, Inc. (Class A and Class B) and members of Gloo Holdings, LLC, are defined as net loss attributable to common stockholders of Gloo Holdings, Inc. (Class A and Class B) and members of Gloo Holdings, LLC and net loss per unit available to members of Gloo Holdings, LLC respectively, adjusted to exclude the impact of (1) loss (gain) from change in fair value of financial instruments, (2) loss on extinguishment of debt, (3) other non-routine items, such as IPO related costs, and (4) the income tax expense (benefit) impact of other adjustments, if any. Non-GAAP net loss per unit available to members of Gloo Holdings, LLC, basic and diluted, includes adjustments made to (U.S. GAAP) net loss attributable to stockholders and members of Gloo Holdings, Inc. and Gloo Holdings, LLC, respectively. The Company has made these non-GAAP adjustments because it believes that these charges are not reflective of its core operating results.

The non-GAAP financial measures included in this press release are not measurements of financial performance under U.S. GAAP and they should not be considered as alternatives to or substitutes for measures of performance derived in accordance with U.S. GAAP. In addition, these non-GAAP measures should not be construed as an inference that the Company’s future results will be unaffected by unusual or non-routine items. These non-GAAP measures have limitations as analytical tools, and investors should not consider such measures either in isolation or as substitutes for analyzing the Company’s results as reported under U.S. GAAP. The Company’s definitions and calculations of these non-GAAP measures are not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation. Investors are encouraged to review the most directly comparable GAAP measure and the Company’s condensed consolidated financial statements and related notes included in Part II, Item 8 of the Annual Report on Form 10-K for the year ended January 31, 2026, which Gloo expects to file with the SEC on or around the date of this press release.

Gloo Holdings, Inc. Consolidated Balance Sheets (unaudited)

	January 31,
	2026			2025
	(in thousands, except share and unit data)
ASSETS
Current assets:
Cash and cash equivalents	$	57,307		$	13,592
Restricted cash		255			252
Accounts receivable, net of allowance for credit losses of $75 and $68, respectively		10,697			623
Inventory, net		1,397			1,460
Contract assets		1,259			—
Prepaid expenses and other current assets		4,689			2,388
Total current assets		75,604			18,315
Property and equipment, net		4,166			2,303
Capitalized software, net		30,078			23,578
ROU operating lease asset		8,705			3,835
Long-term investments		100			33,252
Other non-current assets		370			209
Intangible assets, net		37,283			11,431
Goodwill		107,353			27,901
Total assets	$	263,659		$	120,824

LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS’ AND MEMBERS’ DEFICIT
Current liabilities:
Accounts payable	$	9,356		$	3,613
Accrued compensation		8,397			4,538
Accrued liabilities		6,414			3,521
Acquisition-related liabilities, current		2,056			1,350
Deferred revenue		14,581			3,725
Debt, current		5,812			3,177
Lease liabilities, current		1,925			685
Total current liabilities		48,541			20,609
Acquisition-related liabilities, non-current		1,346			100
Debt, non-current		29,485			66,959
Lease liabilities, non-current		7,076			3,095
Derivative liability		399			832
Deferred income taxes		4,353			1,911
MW Call Option		12,858			8,793
Other non-current liabilities		1,919			4,633
Total liabilities		105,977			106,932

Mezzanine Equity:
Series A Preferred Units, no par value; no units authorized, issued or outstanding, with zero liquidation preference as of January 31, 2026; and 39,250,615 authorized, 37,809,982 units issued, and 37,532,207 units outstanding, with an aggregate liquidation preference of $432.7 million as of January 31, 2025		—			351,887
Redeemable NCI		3,559			—
Total mezzanine equity		3,559			351,887

Stockholders’ and Members’ Equity:
Preferred stock, par value $0.001 per share, 100,000,000 shares authorized, and no shares issued or outstanding as of January 31, 2026		—			—
Common member units, no par value; no units authorized, issued or outstanding as of January 31, 2026; and 13,217,025 units authorized and 8,201,191 units issued and outstanding as of January 31, 2025		—			—
Class A, $0.001 par value, 5,000,000,000 shares authorized, and 11,405,352 issued and outstanding as of January 31, 2026		11			—
Class B, $0.001 par value, 100,000,000 shares authorized, 69,465,772 issued and 69,166,937 outstanding as of January 31, 2026		70			—
Treasury stock, at cost; 298,835 shares as of January 31, 2026; and no shares as of January 31, 2025		(3,771	)		—
Additional paid-in capital		178,619			23,591
Accumulated deficit		(40,119	)		(368,312	)
Accumulated other comprehensive income		364			—
Equity attributable to stockholders’ and members’		135,174			(344,721	)
Equity attributable to noncontrolling interests		18,949			6,726
Total stockholders’ and members’ equity		154,123			(337,995	)
Total liabilities, mezzanine equity, and stockholders’ and members’ equity	$	263,659		$	120,824

Gloo Holdings, Inc. Consolidated Statements of Operations (unaudited)

	Three Months Ended January 31,						Year Ended January 31,
	2026			2025			2026			2025
	(in thousands, except share, per share, unit, and per unit data)
Revenue:
Platform revenue	$	20,143		$	6,323		$	57,208		$	22,873
Platform solutions revenue		13,490			173			37,452			330
Other revenue		—			—			—			13
Total revenue		33,633			6,496			94,660			23,216
Operating expenses:
Cost of revenue (exclusive of depreciation and amortization)		25,739			5,417			71,554			19,749
Product development		6,878			3,594			23,744			13,551
Sales and marketing		12,387			6,478			36,354			22,619
General and administrative		20,538			4,784			60,016			15,098
Depreciation and amortization		3,117			2,154			11,163			7,714
Impairment of goodwill		—			27,753			—			27,753
Total operating expenses		68,659			50,180			202,831			106,484
Operating loss		(35,026	)		(43,684	)		(108,171	)		(83,268	)
Other expense (income):
Interest expense		1,954			1,884			14,347			4,738
Other income, net		(2,037	)		(150	)		(2,367	)		(687	)
Loss (gain) from change in fair value of financial instruments		13,025			(543	)		33,528			(1,301	)
Loss on extinguishment of debt		—			—			7,473			—
Total other expense (income), net		12,942			1,191			52,981			2,750
Net loss before income taxes		(47,968	)		(44,875	)		(161,152	)		(86,018	)
Income tax (expense) benefit		(680	)		236			(362	)		796
Income (loss) from equity method investments, net		—			(143	)		2,782			(580	)
Net loss		(48,648	)		(44,782	)		(158,732	)		(85,802	)
Less: net loss attributable to noncontrolling interests		681			(113	)		(1,604	)		(113	)
Net loss attributable to stockholders and members of Gloo Holdings, Inc. and Gloo Holdings, LLC, respectively	$	(49,329	)	$	(44,669	)	$	(157,128	)	$	(85,689	)

Net loss per share attributable to common stockholders of Gloo Holdings, Inc. (Class A and Class B) and units of members of Gloo Holdings, LLC, respectively	$	(0.77	)	$	(6.14	)	$	(8.03	)	$	(13.65	)
Weighted-average common shares (Class A and Class B) of Gloo Holdings, Inc. and units of Gloo Holdings, LLC used to compute net loss per share and unit, respectively, basic and diluted		65,596,225			8,125,002			22,696,229			7,764,474

Gloo Holdings, Inc. Consolidated Statements of Cash Flows (unaudited)

	Year Ended January 31,
	2026			2025
	(in thousands)
Operating activities:
Net loss	$	(158,732	)	$	(85,802	)
Adjustments to reconcile net loss attributable to common stockholders and members to net cash used in operating activities:
Equity-based compensation expense		15,450			3,787
Depreciation and amortization		11,163			7,714
Amortization of deferred financing costs		3,249			692
Provision for expected credit losses		396			64
Provision for inventory write-offs		123			274
Lease expense		2,098			1,179
Deferred income taxes		(141	)		(796	)
Loss (gain) from change in fair value of financial instruments		33,528			(1,301	)
(Income) loss from equity method investments, net		(2,782	)		580
Loss on extinguishment of debt		7,473			—
Debt assumed through PIK interest		3,474			1,381
Impairment of goodwill		—			27,753
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(2,864	)		(236	)
Prepaid expenses and other current assets		(40	)		(1,173	)
Other non-current assets		(1,249	)		(50	)
Accounts payable		2,814			(63	)
Accrued expenses and other current liabilities		3,820			(904	)
Deferred revenue		1,611			1,571
Other non-current liabilities		110			(804	)
Net cash used in operating activities		(80,499	)		(46,134	)
Investing activities:
Purchases of property and equipment		(1,189	)		(425	)
Capitalized internal-use software costs		(12,822	)		(10,169	)
Purchases of equity method investments		—			(2,401	)
Acquisitions, net of cash acquired		(10,234	)		(1,931	)
Net cash used in investing activities		(24,245	)		(14,926	)
Financing activities:
Payments on debt		(4,316	)		(230	)
Proceeds from debt		81,925			60,680
Payments of deferred financing costs		(85	)		(87	)
Proceeds from Member Advances received, net		5,000			489
Proceeds from Series A Preferred Units issuance		817			—
Proceeds from exercise of common stock and common unit options		639			325
Proceeds from issuance of Class A common stock upon initial public offering, net of underwriting discounts and commissions and other offering costs		64,991			—
Net cash provided by financing activities		148,971			61,177
Effect of exchange rate changes on cash and cash equivalents		(509	)		—
Net increase in cash, cash equivalents and restricted cash		43,718			117
Cash, cash equivalents, and restricted cash
Beginning of period		13,844			13,727
End of period	$	57,562		$	13,844
Supplemental disclosures of cash flow information:
Cash paid for interest	$	4,013		$	3,442
Cash paid for taxes, net of refunds		167			—
Supplemental disclosure of non-cash investing and financing activity:
ROU assets obtained in acquisition		2,206			—
ROU assets obtained in exchange for new lease liabilities		1,934			—

Gloo Holdings, Inc. GAAP to Non-GAAP Reconciliation (unaudited)

The following tables provide a reconciliation of our non-GAAP financial measures to their most directly comparable GAAP financial measures for the periods presented:

	Three Months Ended January 31,						Year Ended January 31,
	2026			2025			2026			2025
	(in thousands)
Net loss attributable to common stockholders and members	$	(49,329	)	$	(44,669	)	$	(157,128	)	$	(85,689	)
Net loss attributable to noncontrolling interests		681			(113	)		(1,604	)		(113	)
Net loss		(48,648	)		(44,782	)		(158,732	)		(85,802	)
Adjusted to exclude:
Interest expense		1,954			1,884			14,347			4,738
Income tax expense (benefit)		680			(236	)		362			(796	)
Depreciation and amortization		3,117			2,154			11,163			7,714
Equity-based compensation		10,522			377			15,450			3,787
Impairment of goodwill		—			27,753			—			27,753
Loss (gain) from change in fair value of financial instruments		13,025			(543	)		33,528			(1,301	)
Restructuring costs		1,680			687			1,680			687
Transaction related bonuses		—			—			732			—
Loss on extinguishment of debt		—			—			7,473			—
Income (loss) from equity method investments, net		—			143			(2,782	)		580
Interest income		(713	)		(146	)		(1,023	)		(665	)
IPO related costs		1,117			—			4,738			—
One-time employee tax credit		(1,285	)		—			(1,285	)		—
Adjusted EBITDA	$	(18,551	)	$	(12,709	)	$	(74,349	)	$	(43,305	)


	Three Months Ended January 31,						Year Ended January 31,
	2026			2025			2026			2025
	(in thousands, except share, per share, unit, and per unit data)
Net loss	$	(48,648	)	$	(44,782	)	$	(158,732	)	$	(85,802	)
Net loss attributable to noncontrolling interests		681			(113	)		(1,604	)		(113	)
Net loss attributable to stockholders and members of Gloo Holdings, Inc. and Gloo Holdings, LLC, respectively		(49,329	)		(44,669	)		(157,128	)		(85,689	)
Adjusted to exclude:
Loss (gain) from change in fair value of financial instruments		13,025			(543	)		33,528			(1,301	)
IPO related costs		1,117			—			4,738			—
Loss on extinguishment of debt		—			—			7,473			—
Income tax impact⁽¹⁾		—			—			—			—
Non-GAAP net loss attributable to stockholders and members of Gloo Holdings, Inc. and Gloo Holdings, LLC, respectively		(35,187	)		(44,670	)		(111,389	)		(86,990	)
Less: Undeclared cumulative dividends on Series A Preferred Units		1,229			5,185			17,694			20,264
Less: Deemed dividend for conversion of Member Advance		—			—			7,400			—
Non-GAAP net loss available to stockholders and members of Gloo Holdings, Inc. and Gloo Holdings, LLC, respectively, LLC basic and diluted	$	(36,416	)	$	(49,855	)	$	(136,483	)	$	(107,254	)

Weighted average number of common units outstanding, basic and diluted		65,596,225			8,125,002			22,696,229			7,764,474

Net loss per share attributable to common stockholders of Gloo Holdings, Inc. (Class A and Class B) and units of members of Gloo Holdings, LLC, respectively	$	(0.77	)	$	(6.14	)	$	(8.03	)	$	(13.65	)
Non-GAAP net loss per unit attributable to common stockholders of Gloo Holdings, Inc. (Class A and Class B) and units of members of Gloo Holdings, LLC, respectively	$	(0.78	)	$	(5.12	)	$	(7.12	)	$	(2.62	)

(1) The adjustments to net loss attributable to members of Gloo Holdings, LLC relate to accounting transactions that are exclusive to Gloo Holdings, LLC, a nontaxable entity.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260414279483/en/

[email protected]

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Data Management Technology Philanthropy Marketing Religion Communications Other Philanthropy Software Artificial Intelligence Networks Consumer

MEDIA:

Logo

April 14, 2026 4:13 pm

NOG Schedules First Quarter 2026 Earnings Release and Conference Call

NOG Schedules First Quarter 2026 Earnings Release and Conference Call

MINNEAPOLIS–(BUSINESS WIRE)–
Northern Oil and Gas, Inc. (NYSE: NOG) (“NOG” or the “Company”) announced today that it plans to issue its first quarter 2026 financial and operating results on Tuesday, April 28, 2026, after the market closes.

In connection with its earnings release, NOG will host a conference call and webcast to discuss its financial results at 8:00 a.m. Central Time on Wednesday, April 29, 2026.

Those wishing to listen to the conference call may do so via phone or the Company’s webcast.

Conference Call and Webcast Details:

Date:		April 29, 2026
Time:		8:00 a.m. Central Time
Dial-In:		(800) 715-9871
International Dial-In:		(646) 307-1963
Conference ID:		4503139
Webcast:		First Quarter 2026 Earnings Conference Call

Replay Information:

A replay of the conference call will be available through May 13, 2026, by dialing:
Dial-In:		(800) 770-2030
International Dial-In:		(647) 362-9199
Conference ID:		4503139

An archive of the conference call webcast will also be available on NOG’s website through April 28, 2027.

ABOUT NOG

NOG is a real asset company with a primary strategy of acquiring and investing in non-operated minority working and mineral interests in the premier hydrocarbon producing basins within the contiguous United States. More information about NOG can be found at www.noginc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260414580386/en/

Evelyn Leon Infurna

Vice President of Investor Relations

(952) 476-9800

[email protected]

KEYWORDS: Minnesota United States North America

INDUSTRY KEYWORDS: Oil/Gas Energy

MEDIA:

Logo

April 14, 2026 4:11 pm

Phreesia Named to Becker’s Hospital Review’s 2026 List of “Revenue Cycle Management Companies to Know”

Phreesia Named to Becker’s Hospital Review’s 2026 List of “Revenue Cycle Management Companies to Know”

ALL-REMOTE COMPANY/WILMINGTON, Del.–(BUSINESS WIRE)–
Phreesia, a leader in patient intake, outreach and activation, has been named to Becker’s Hospital Review’s2026 list of “Revenue Cycle Management Companies to Know.” The annual list recognizes companies that play a critical role in helping healthcare organizations manage the growing complexity of revenue cycle operations, including patient access, intake, billing and reimbursement.

The 2026 list highlights organizations driving innovation and performance across the revenue cycle. Phreesia helps providers digitize intake and manage payment workflows before, during and after patient visits, improving collections and reducing manual administrative work.

“We’re honored to be recognized by Becker’s for our revenue cycle management solutions that support healthcare organizations nationwide,” said Chaim Indig, CEO and co-founder of Phreesia. “Our focus is on helping providers connect intake and payments so they can accelerate cash flow, simplify workflows and operate more efficiently.”

Phreesia’s platform brings payment processing into a single, central location, supporting everything from insurance verification and copay calculation to card-on-file and post-visit payments. Its payment solutions, including Phreesia Bill Pay, help providers get paid faster, improve visibility into payment activity and reduce the cost to collect.

For more information on Phreesia, visit www.phreesia.com.

About Phreesia

Phreesia is the trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 180 million patient visits in 2025—1 in 6 visits across the U.S. This scale allows Phreesia to make meaningful impact across the healthcare ecosystem. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives operational efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260414833783/en/

Media Contact:

Jason Rost

[email protected]

613-809-8136

KEYWORDS: Delaware United States North America

INDUSTRY KEYWORDS: Technology Payments Human Resources Hospitals Health Technology Professional Services Software Practice Management General Health Health

MEDIA:

Logo

Posted on April 14, 2026 4:10 pm
SurgePays Reports Full Year 2025 Results and Highlights Scalable Growth Model with Improved Cost Structure Entering 2026

Reduced Cash Burn and Expansion Across Multiple Revenue Channels Support a More Efficient Growth Model

BARTLETT, Tenn., April 14, 2026 (GLOBE NEWSWIRE) — SurgePays, Inc. (NASDAQ: SURG) (“SurgePays” or the “Company”), a wireless and fintech technology company connecting subprime and underserved consumers to essential mobile and financial services, today reported its financial results for the year ended December 31, 2025.

Brian Cox, President and CEO of SurgePays, stated, “2025 was a year where we demonstrated the scalability of our platform and repositioned the business for more disciplined growth. We delivered steady sequential revenue growth through the first three quarters, increasing from approximately $10.6 million in Q1 to $11.5 million in Q2, and reaching $18.7 million in Q3. That third quarter demonstrated how quickly we can scale when capital is deployed into subscriber growth.”

Mr. Cox continued, “In Q3, we deployed capital into subscriber acquisition and saw a clear step-function increase in revenue. In Q4, we reduced that level of spend to prioritize capital efficiency. While revenue declined sequentially from Q3, it remained significantly higher than the fourth quarter of 2024. The key takeaway is that we have demonstrated both the ability to scale and discipline to manage that growth.”

“Equally important, we materially improved our cost structure. Total general and administrative expenses declined to approximately $20.1 million in 2025 from $27.5 million in 2024. Q4 included items that are not indicative of our current operating run rate, including legal and certain non-cash expenses. Since year end, we have taken additional actions to reduce operating expenses. Based on those actions, we estimate our current monthly cash burn at the end of the first quarter of 2026 to be approximately $250,000 to $300,000.”

Mr. Cox added, “Today, SurgePays is operating with multiple revenue channels, including government-subsidized wireless, LinkUp Mobile prepaid, wholesale MVNE relationships, and our point-of-sale fintech and data platforms. We are no longer dependent on a single program. With an established retail footprint of more than 9,000 locations, a customer acquisition engine through ProgramBenefits.com, and additional monetization initiatives such as our Managed Marketing Services platform, we are positioned to grow in a more controlled and capital efficient way.”

Full Year 2025 Operational Highlights:

Repositioned the business following the conclusion of the Affordable Connectivity Program, expanding across multiple revenue channels, including wireless, wholesale, and fintech solutions.

Generated $13.5 million in MVNO revenue, representing approximately 24% of total revenue for the year.

Completed integration with the AT&T best-in-class network, strengthening network performance and service quality.

Launched LinkUp Mobile nationwide, expanding prepaid wireless offerings and contributing to growth in the Point-of-Sale and Prepaid Services segment, which generated approximately $43.5 million, or approximately 76% of total revenue.

Continued expansion of the Company’s retail distribution network, supporting wireless activations and fintech transactions across more than 9,000 locations.

Advanced MVNE platform capabilities, supporting wholesale wireless enablement opportunities.

Launched ProgramBenefits.com, establishing a scalable digital channel for customer acquisition and monetization beyond wireless services.

Executed cost optimization initiatives, reducing general and administrative expenses by approximately 28% year over year.

Subsequent Operational Highlights:

LinkUp Mobile surpassed 100,000 subscriber lines, reflecting continued momentum in the Company’s prepaid wireless business.

Expanded digital acquisition initiatives through ProgramBenefits.com.

Deployed the Company’s Managed Marketing Services platform, enabling in-store digital advertising and introducing an additional monetization layer.

Initiated buy-one-get-one promotional campaign to drive subscriber growth and increase market penetration.

Entered into a strategic partnership with Alpha Modus to expand distribution of fintech and consumer engagement solutions.

Launched a fully integrated stored value and loyalty platform, enabling merchants to offer branded gift cards, store credit, and loyalty programs through the SurgePays point-of-sale system.

Full Year 2025 Financial Highlights:

Revenue totaled approximately $57.0 million, compared to $60.9 million in 2024, reflecting the expected impact from the conclusion of the Affordable Connectivity Program in mid-2024 and the Company’s transition to a more diversified revenue model.

Gross loss improved to approximately $(10.6) million, compared to $(14.3) million in 2024.

Total general and administrative expenses declined to approximately $20.1 million, compared to $27.5 million in 2024.

Operating loss improved to approximately $(30.7) million, compared to $(41.8) million in 2024.

Fourth Quarter and Full Year 2025
Financial Results Conference Call

Date: Tuesday, April 14, 2026
Time: 5:00 p.m. ET
Dial-in Number: 1-888-506-0062
Access Code: 395490
Webcast: https://ir.surgepays.com/company-events

Replay of the webcast will be available for a one year period.

About SurgePays, Inc.

SurgePays, Inc. (NASDAQ: SURG) is a wireless and fintech technology company focused on expanding access to essential mobile and financial services for subprime and underserved consumers. The Company operates a nationwide ecosystem that includes its own wireless brands and a proprietary point of sale platform inside thousands of retail locations. This infrastructure supports SIM activations, top-ups, financial transactions, and other digital services used daily by prepaid and underbanked customers.

SurgePays is building on this foundation by expanding into data driven marketing and digital partnerships that monetize verified consumer engagement and increase revenue per retail location. The Company’s strategy is to build an integrated platform that serves as the operating system for independent retailers while creating recurring revenue streams across wireless, fintech, digital marketing, and stored value programs.

Visit www.SurgePays.com for more information.

SurgePays Cautionary Note Regarding Forward-Looking Statements

This press release includes express or implied statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Forward-looking statements involve substantial risks and uncertainties and generally relate to future events or our future financial or operating performance. These statements may include projections, guidance, or other estimates regarding revenue, cash flow, business growth, market expansion, or customer acquisition, and statements regarding subscriber growth, distribution expansion, and operating scale.

In some cases, you can identify forward-looking statements by words such as “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” or similar terminology.

Although we believe the expectations reflected in these forward-looking statements are reasonable, they involve known and unknown risks and uncertainties that may cause actual results to differ materially from those described in the forward-looking statements. These risks include, but are not limited to, our ability to scale our prepaid wireless business, maintain retail distribution relationships, expand our merchant platform, and achieve anticipated subscriber growth.

Additional information regarding these and other risks can be found in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The forward-looking statements in this press release speak only as of the date they are made, and the Company undertakes no obligation to update them except as required by law.

Investor Contact:

Valter Pinto
Managing Director
KCSA Strategic Communications
212.896.1254
[email protected]

SurgePays, Inc. and Subsidiaries

Consolidated Balance Sheets

December 31,

2025 December 31,
2024

Assets

Current Assets

Cash and cash equivalents $ 1,731,400 $ 11,790,389

Restricted cash – line of credit reserve 281,811 –

Restricted cash – held in escrow – 1,000,000

Accounts receivable – net 4,045,162 3,000,209

Inventory 339,570 1,781,365

Prepaids and other 581,823 298,360

Total Current Assets 6,979,766 17,870,323

Property and equipment – net 403,517 591,088

Other Assets

Note receivable – 176,851

Intangibles – net 819,153 1,472,962

Goodwill – 3,300,000

Operating lease – right of use asset – net 313,410 564,781

Total Other Assets 1,132,563 5,514,594

Total Assets $ 8,515,846 $ 23,976,005

Liabilities and Stockholders’ Equity (Deficit)

Current Liabilities

Accounts payable and accrued expenses $ 10,219,011 $ 3,929,195

Accounts payable and accrued expenses – related party 117,546 192,845

Operating lease liability 219,997 248,069

Notes payable 1,834,008 –

Note payable – related party 2,730,796 1,689,367

Convertible notes payable – net 3,068,878 –

Total Current Liabilities 18,190,236 6,059,476

Long Term Liabilities

Note payable – related party – 1,866,288

Notes payable – SBA government 458,334 469,396

Operating lease liability 99,235 319,232

Convertible notes payable – net 5,170,860 –

Total Long Term Liabilities 5,728,429 2,654,916

Total Liabilities 23,918,665 8,714,392

Stockholders’ Equity (Deficit)

Common stock, $0.001 par value, 500,000,000 shares authorized 21,847,927 and 20,431,549 shares issued and 21,151,974 and 20,068,929 shares outstanding, at December 31, 2025 and December 31, 2024, respectively 21,852 20,435

Additional paid-in capital 83,246,736 76,842,878

Treasury stock – at cost (695,953 and 362,620 shares, respectively) (1,631,966 ) (631,967 )

Accumulated deficit (96,984,297 ) (60,915,427 )

Stockholders’ equity (deficit) (15,347,675 ) 15,315,919

Non-controlling interest (55,144 ) (54,306 )

Total SurgePays Inc. Stockholders’ Equity (Deficit) (15,402,819 ) 15,261,613

Total Liabilities and Stockholders’ Equity (Deficit) $ 8,515,846 $ 23,976,005

SurgePays, Inc. and Subsidiaries

Consolidated Statements of Operations

For the Years Ended December 31,

2025 2024

Revenues, net $ 56,962,920 $ 60,881,173

Costs and expenses

Cost of revenues 67,551,811 75,205,372

General and administrative expenses 20,071,121 27,458,152

Total costs and expenses 87,622,932 102,663,524

Loss from operations (30,660,012 ) (41,782,351 )

Other income (expense)

Interest expense (including amortization of debt discount) (2,003,935 ) (554,200 )

Loss on lease termination – net – (194,863 )

Other income 7,140 636,868

Interest income 63,950 105,395

Realized gains – investments – 13,613

Dividends, interest and other income – investments – 355,549

Gain on investment in CenterCom – 33,864

Impairment loss – note receivable (176,851 ) –

Impairment loss – CenterCom – (498,273 )

Impairment loss – internal use software development costs – (316,594 )

Impairment loss – goodwill (3,300,000 ) (866,782 )

Total other income (expense) – net (5,409,696 ) (1,285,423 )

Net income (loss) before provision for income taxes (36,069,708 ) (43,067,774 )

Provision for income tax benefit (expense) – (2,870,000 )

Net income (loss) including non-controlling interest (36,069,708 ) (45,937,774 )

Non-controlling interest (838 ) (208,550 )

Net income (loss) available to common stockholders $ (36,068,870 ) $ (45,729,224 )

Earnings per share – attributable to common stockholders

Basic $ (1.80 ) $ (2.39 )

Diluted $ (1.80 ) $ (2.39 )

Weighted average number of shares outstanding – attributable to common stockholders

Basic 20,085,138 19,119,181

Diluted 20,085,138 19,119,181

SurgePays, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

For the Years Ended December 31,

2025 2024

Operating activities

Net loss – including non-controlling interest $ (36,069,708 ) $ (45,937,774 )

Adjustments to reconcile net loss to net cash used in operations

Depreciation and amortization 859,970 942,450

Amortization of right-of-use assets 251,371 126,970

Amortization of debt discount/debt issue costs 759,926 –

Amortization of internal use software development costs – 222,830

Impairment loss – CenterCom – 498,273

Impairment loss – internal use software development costs – 316,594

Impairment loss – goodwill – Clearline 2,500,000 866,782

Impairment loss – goodwill – Torch 800,000 –

Impairment loss – note receivable 176,851 –

Stock issued for services 641,430 411,740

Recognition of stock based compensation – unvested shares – related parties 939,990 6,752,706

Recognition of share based compensation – options 1,149,449 986,244

Recognition of share based compensation – options – related party 552,286 622,949

Realized gain in sale of investments – (13,613 )

Interest expense adjustment – SBA loans – 19,750

Right-of-use asset lease payment adjustment true up – (267,347 )

Gain on equity method investment – CenterCom – (33,864 )

Cash paid for lease termination – (212,175 )

Loss on lease termination – net – 194,863

Changes in operating assets and liabilities

(Increase) decrease in

Accounts receivable (1,044,953 ) 6,535,865

Inventory 1,441,795 7,265,229

Prepaids and other (283,463 ) (136,427 )

Deferred income taxes – net – 2,835,000

Increase (decrease) in

Accounts payable and accrued expenses 6,355,272 (2,509,925 )

Accounts payable and accrued expenses – related party (75,299 ) (356,388 )

Accrued income taxes payable – (570,000 )

Deferred revenue – (20,000 )

Operating lease liability (248,069 ) 148,665

Net cash used in operating activities (21,293,152 ) (21,310,603 )

Investing activities

Purchase of property and equipment (18,590 ) (518,189 )

Purchase of investments – net – (10,159,444 )

Proceeds from sale of investments – 10,173,057

Cash paid for acquisition of Clearline Mobile, Inc. – (2,500,000 )

Net cash used in investing activities (18,590 ) (3,004,576 )

Financing activities

Proceeds from stock issued for cash 1,774,636 17,249,994

Proceeds from exercise of common stock warrants – 8,799,257

Cash paid as direct offering costs – common stock (123,197 ) (1,395,000 )

Proceeds from issuance of notes payable 6,628,811 –

Repayments of notes payable (4,751,765 ) –

Proceeds from issuance of convertible notes payable 8,450,000 –

Cash paid as direct offering costs – convertibles note payable (608,000 ) –

Repayments of loans – related party (824,859 ) (1,527,899 )

Repayments on notes payable – SBA government (11,062 ) (10,877 )

Treasury shares repurchased (share buy-backs) – (631,967 )

Net cash provided by financing activities 10,534,564 22,483,508

Net decrease in cash, cash equivalents and restricted cash (10,777,178 ) (1,831,671 )

Cash, cash equivalents and restricted cash – beginning of year 12,790,389 14,622,060

Cash, cash equivalents and restricted cash – end of year $ 2,013,211 $ 12,790,389

Supplemental disclosure of cash flow information

Cash paid for interest $ 245,855 $ 470,208

Cash paid for income tax $ – $ –

Supplemental disclosure of non-cash investing and financing activities

Treasury stock reacquired in connection with convertible debt financing $ 999,999 $ –

Debt discount – convertible notes payable – original issue discount $ 245,000 $ –

Debt discount – convertible notes payable – issuance of common stock $ 271,880 $ –

Debt discount – convertible notes payable – issuance of warrants $ 1,084,927 $ –

Debt discount – convertible notes payable – stated interest $ 215,600 $ –

Debt discount – note payable – issuance of warrants $ 48,418 $ –

Stock issued in settlement of accounts payable $ 65,456 $ –

Reclassification of accrued interest – related party to note payable – related party $ – $ 498,991

Exercise of warrants – cashless $ – $ 41

Termination of ROU operating lease assets and liabilities $ – $ 327,139

Right-of-use asset obtained in exchange for new operating lease liability $ – $ 664,288

Posted on April 14, 2026 4:10 pm
Mama’s Creations Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Fourth Quarter Revenue Grows 61% to $54.0 Million; Net Income Increases 38% to $2.2 Million with Adjusted EBITDA of $5.5 Million; Cash Position Nearly Triples in Fiscal 2026 to $20.0 Million

EAST RUTHERFORD, NJ, April 14, 2026 (GLOBE NEWSWIRE) —
Mama’s Creations, Inc. (Nasdaq: MAMA), a leading national marketer and manufacturer of fresh deli prepared foods, has reported its financial results for fourth quarter and fiscal year ended January 31, 2026.

Financial Summary:

Three Months Ended Jan. 31, Fiscal Year Ended Jan. 31,

$ in millions 2026 2025 % Increase 2026 2025 % Increase

Revenues $ 54.0 $ 33.6 61 % $ 171.7 $ 123.3 39 %

Gross Profit $ 14.0 $ 9.1 54 % $ 43.0 $ 30.5 41 %

Operating Expenses $ 10.9 $ 7.2 51 % $ 35.9 $ 25.7 40 %

Net Income $ 2.2 $ 1.6 38 % $ 5.3 $ 3.7 43 %

Earnings per Share (Diluted) $ 0.05 $ 0.04 25 % $ 0.13 $ 0.09 44 %

Adj. EBITDA (non-GAAP) $ 5.5 $ 3.1 77 % $ 15.4 $ 10.1 52 %

Fourth Quarter Fiscal 2026 & Subsequent Operational Highlights:

Continued successful integration initiatives at the Company’s Bay Shore, NY facility acquired from Crown 1 Enterprises, with gross margin improvement on track toward mid-to-high-20% corporate target, and cross-selling initiatives gaining traction with Crown 1’s premium customer base.

Secured major new tier-1 national retail placements, including expansion at Wal-Mart, new introductions at Food Lion, confirmed wins at Target, as well as Everyday Item status in Costco’s Northeast region following a successful Costco National Multi-Vendor Mailer (MVM) with branded Beef Meatballs.

Invited to present at leading investor conferences nationally, including the Craig-Hallum Alpha Select Conference, Stephens NASH25 Conference, ROTH Deer Valley Event, Oppenheimer Emerging Growth Conference, and the DA Davidson CEO Forum.

Cash and cash equivalents as of January 31, 2026 totaled $20.0 million, as compared to $7.2 million as of January 31, 2025. The increase was primarily driven by improved profitability, strong operating cash flow generation, and ongoing working capital optimization.

Management Commentary

Adam L. Michaels, Chairman and CEO of Mama’s Creations, said: “Fiscal 2026 was a landmark year for Mama’s Creations. We delivered 39% revenue growth to $171.7 million, expanded adjusted EBITDA by over 50%, and fundamentally transformed our operating platform with the acquisition and successful integration of Crown 1’s Bay Shore facility. This reflects the continued strength of our organic growth engine combined with the accretive contribution of our M&A activities.

“On the operations front, the Bay Shore integration continues to be a resounding success. In just a few months, we have centralized procurement across all three facilities, transitioned production to optimize capacity utilization, and begun realizing meaningful cost synergies. Bay Shore’s gross margin trajectory is on track toward our mid-to-high-20% corporate target, and the facility’s premium customer base is opening cross-selling opportunities that were previously out of reach. Most importantly, we have grown our family, adding close to 200 employees that share our values, culture and aspiration to become a $1B one-stop-shop in the deli prepared food category.

“Our Costco partnership continues to accelerate – evolving from $0.5 million in fiscal 2023 to exceeding $10 million in Q1 of fiscal 2026 alone, culminating in our first National Print MVM and securing everyday item status in the Northeast region. Beyond Costco, additional placements at Walmart and new wins at Target are driving meaningful scale across all channels.

“Our 4 Cs strategy – Cost, Controls, Culture, and Catapult – is driving growth at 5x the category rate. Product innovation including our NAE chicken offerings, artisan cut products, and successful panini line, are positioning us to capture share in a large, highly fragmented, underpenetrated market.

“Looking ahead, the combination of strong organic growth, expanding and deepening retail distribution, and a well-defined M&A strategy gives us confidence in our ability to deliver sustained, profitable growth and long-term value for our shareholders,” concluded Michaels.

Fourth Quarter and Full Year Fiscal 2026 Financial Results

Revenue for the fourth quarter of fiscal 2026 increased 60.7% to $54.0 million, as compared to $33.6 million in the same year-ago quarter. Revenue for fiscal year 2026 increased 39.2% to $171.7 million, as compared to $123.3 million in the prior year. The increase was primarily due to item expansion at existing customers, successful high-ROI promotional activities that accelerated velocities, initial placements at new customers, and the acquisition of Crown 1.

Gross profit increased 53.8% to $14.0 million, or 25.9% of total revenues, in the fourth quarter of fiscal 2026, as compared to $9.1 million, or 27.0% of total revenues, in the same year-ago quarter. Gross profit increased 41.0% to $43.0 million, or 25.1% of total revenues, in fiscal 2026, as compared to $30.5 million, or 24.8% of total revenues, in the prior year. The fourth quarter gross margin was impacted by the continued ramp of the Bay Shore facility, while the improvement in full-year gross margin reflects the operational efficiencies, procurement optimization, and stabilized commodity costs across the platform.

Operating expenses totaled $10.9 million in the fourth quarter of fiscal 2026, as compared to $7.2 million in the same year-ago quarter. As a percentage of revenue, operating expenses declined to 20.2% from 21.4% in the prior year quarter. For the full year, operating expenses totaled $35.9 million, as compared to $25.7 million in the prior year. As a percentage of revenue, operating expenses were 20.9% in fiscal 2026, as compared to 20.8% in the prior year. The change was partially due to the Bay Shore acquisition, new digital strategies and enhanced product marketing, new management hires and further technology upgrades to drive actionable insights faster and deeper into the organization.

Net income for the fourth quarter of fiscal 2026 increased 37.5% to $2.2 million, or $0.05 per diluted share, as compared to net income of $1.6 million, or $0.04 per diluted share, in the same year-ago quarter. Net income for fiscal 2026 increased 43.2% to $5.3 million, or $0.13 per diluted share, as compared to net income of $3.7 million, or $0.09 per diluted share, in the prior year. Fourth quarter net income totaled 4.1% of revenue, as compared to 4.8% in the same year-ago quarter.

Adjusted EBITDA, a non-GAAP measure, increased 77.4% to $5.5 million for the fourth quarter of fiscal 2026, as compared to $3.1 million in the same year-ago quarter. Adjusted EBITDA increased 52.5% to $15.4 million in fiscal 2026, as compared to $10.1 million in the prior year.

Cash and cash equivalents as of January 31, 2026 totaled $20.0 million, as compared to $7.2 million as of January 31, 2025. The significant increase was primarily driven by improved profitability, strong operating cash flow generation, and ongoing working capital optimization. As of January 31, 2026, total debt stood at $5.4 million.

Conference Call

Management will host an investor conference call at 4:30 p.m. Eastern time today, Tuesday, April 14, 2026 to discuss the Company’s fourth quarter fiscal 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

Q4 FY2026 Earnings Conference Call

Date: Tuesday, April 14, 2026
Time: 4:30 p.m. Eastern time
U.S. Dial-in: 1-877-451-6152
International Dial-in: 1-201-389-0879
Conference ID: 13759666
Webcast: MAMA Q4 FY2026 Earnings Conference Call

Please join at least five minutes before the start of the call to ensure timely participation.

A playback of the call will be available through Sunday, June 14, 2026. To listen, please call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 13759666. A webcast replay will also be available using the webcast link above.

About Mama’s Creations, Inc.

Mama’s Creations, Inc. (Nasdaq: MAMA) is a leading marketer and manufacturer of fresh deli prepared foods, found in over 12,000 grocery, mass, club and convenience stores nationally. The Company’s broad product portfolio, born from MamaMancini’s rich history in Italian foods, now consists of a variety of high quality, fresh, clean and easy to prepare foods to address the needs of both our consumers and retailers. Our vision is to become a one-stop-shop deli solutions platform, leveraging vertical integration and a diverse family of brands to offer a wide array of prepared foods to meet the changing demands of the modern consumer. For more information, please visit mamascreations.com.

Use of Non-GAAP Financial Measures

This press release includes the following non-GAAP measure – adjusted EBITDA, which is not a measure of financial performance under GAAP and should not be considered as an alternative to net income as a measure of financial performance. The company believes this non-GAAP measure, when considered together with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to the company’s results of operations. However, this non-GAAP measure has significant limitations in that it does not reflect all the costs and other items associated with the operation of the company’s business as determined in accordance with GAAP. In addition, the company’s non-GAAP measures may be calculated differently and are therefore not comparable to similar measures by other companies. Therefore, investors should consider non-GAAP measures in addition to, and not as a substitute for, or superior to, measures of financial performance in accordance with GAAP. For a definition and reconciliation of EBITDA to net income, its corresponding GAAP measure, please see the reconciliation table shown in this press release below.

US-GAAP Net Income to Adjusted EBITDA Reconciliation (Unaudited)

(in thousands)

THREE MONTHS ENDED Fiscal Year Ended

January 31, January 31,

2026 2025 2026 2025

Net income available to common stockholders $ 2,232 $ 1,600 $ 5,286 $ 3,711

Depreciation 1,171 535 3,270 1,592

Amortization 493 286 1800 1571

Taxes 731 287 1,565 995

Interest, net 37 82 224 259

Stock-based compensation 789 298 1,962 1,099

One time charges 70 0 1,314 900

Adjusted EBITDA (Non-GAAP) $ 5,523 $ 3,088 $ 15,421 $ 10,127

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include information about management’s view of the Company’s future expectations, plans and prospects, including future business opportunities or strategies and are generally preceded by words such as “anticipate,” “believe,” “eventually,” “expect,” “future,” “may,” “look forward to,” “plan,” “projected,” “should,” “will,” and other words that convey the uncertainty of future events or outcomes. You are cautioned that such statements are subject to a multitude of known and unknown risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Certain of these risk factors and others are included in documents the Company files with the Securities and Exchange Commission, including but not limited to, the Company’s Annual Report on Form 10-K for the year ended January 31, 2026, as well as subsequent reports filed with the Securities and Exchange Commission.

The Company has based these forward-looking statements on its current expectations and assumptions about future events. While management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory, and other factors, contingencies, and uncertainties, most of which are difficult to predict and many of which are beyond the Company’s control. You are urged not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Except as may be required by applicable law or regulation, the Company does not undertake, and specifically disclaims, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

Investor Relations Contact:

Lucas A. Zimmerman
Managing Director
MZ Group – MZ North America
(949) 259-4987
[email protected]
www.mzgroup.us

Consolidated Balance Sheets

Mama’s Creations, Inc.

(In thousands, except share and per share data)

January 31, 2026 January 31, 2025

Assets:

Current Assets:

Cash and cash equivalents $ 19,951 $ 7,150

Accounts receivable, net 13,072 8,131

Inventories, net 9,647 4,817

Prepaid expenses and other current assets 2,411 1,779

Total Current Assets 45,081 21,877

Property, plant, and equipment, net 20,108 9,387

Intangible assets, net 3,090 3,436

Goodwill 9,447 8,633

Operating lease right of use assets, net 7,877 3,376

Deferred tax asset — 258

Security deposits 95 95

Total Assets $ 85,698 $ 47,062

Liabilities and Stockholders’ Equity:

Liabilities:

Current Liabilities:

Accounts payable and accrued expenses $ 17,800 $ 12,052

Term loan, net of debt discount of $216 and $22, respectively 960 1,530

Operating leases liabilities 1,690 848

Finance leases payable 321 345

Promissory notes – related parties — 2,250

Total Current Liabilities 20,771 17,025

Term loan – net of current 4,412 1,342

Operating leases liability – net of current 6,204 2,600

Deferred tax liability 813 —

Finance leases payable – net of current 878 1,199

Total Long-Term Liabilities 12,307 5,141

Total Liabilities 33,078 22,166

Commitments and contingencies (Note 11 and 12)

Stockholders’ Equity:

Series A Preferred stock, $0.00001 par value; 120,000 shares authorized; 23,400 issued as of January 31, 2026 and January 31, 2025, 0 shares outstanding as of January 31, 2026 and January 31, 2025 — —

Series B Preferred stock, $0.00001 par value; 200,000 shares authorized; 0 and 0 shares issued and outstanding as of January 31, 2026 and January 31, 2025 — —

Preferred stock, $0.00001 par value; 19,680,000 shares authorized; 0 and 0 shares issued and outstanding as of January 31, 2026 and January 31, 2025 — —

Common stock, $0.00001 par value; 250,000,000 shares authorized; 40,887,000 and 37,826,000 shares issued as of January 31, 2026 and January 31, 2025, respectively, 40,657,000 and 37,596,000 shares outstanding as of January 31, 2026 and January 31, 2025, respectively — —

Additional paid-in capital 47,320 24,882

Retained earnings 5,450 164

Less: Treasury stock, 230,000 shares at cost (150 ) (150 )

Total Stockholders’ Equity 52,620 24,896

Total Liabilities and Stockholders’ Equity $ 85,698 $ 47,062

Consolidated Statements of Operations

Mama’s Creations, Inc.

(in thousands, except per share data)

For the Fiscal Years Ended

January 31,

2026 2025 2024

Net sales $ 171,714 $ 123,328 $ 103,284

Costs of sales 128,668 92,795 72,951

Gross profit 43,046 30,533 30,333

Operating expenses:

Research and development 288 455 414

Selling, general and administrative 35,646 25,201 21,029

Total operating expenses 35,934 25,656 21,443

Income from operations 7,112 4,877 8,890

Other income (expenses)

Interest expense (435 ) (477 ) (549 )

Interest income 211 218 —

Amortization of debt discount (37 ) (16 ) (22 )

Other income — 104 27

Total other expenses (261 ) (171 ) (544 )

Income before income tax provision and income from equity method investment 6,851 4,706 8,346

Income from equity method investment — — 223

Income tax provision (1,565 ) (995 ) (2,008 )

Net income 5,286 3,711 6,561

Less: series B preferred dividends — — (49 )

Net income available to common stockholders 5,286 3,711 6,512

Net income per common share

– basic $ 0.14 $ 0.10 $ 0.18

– diluted $ 0.13 $ 0.09 $ 0.17

Weighted average common shares outstanding

– basic 38,902,364 37,427,571 36,814,162

– diluted 41,380,364 39,418,571 38,381,407

Consolidated Statements of Cash Flows

Mama’s Creations, Inc.

(in thousands)

For the Fiscal Years Ended January 31,

2026 2025 2024

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income $ 5,286 $ 3,711 $ 6,561

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation 3,270 1,592 1,043

Provision for credit losses 90 — (140 )

Amortization of debt discount 37 16 22

Change in right of use assets 1,405 (1,585 ) 348

Amortization of intangible assets 1,619 1,543 1,080

Stock-based compensation 1,963 1,099 436

Allowance for obsolete inventory 24 — 63

Change in deferred tax asset 1,071 245 215

Income from equity method investment — — (223 )

Changes in operating assets and liabilities:

Accounts receivable (1,306 ) (272 ) 2,392

Inventories (3,518 ) (1,507 ) 263

Prepaid expenses and other current assets (868 ) (1,341 ) (540 )

Security deposits — — (35 )

Accounts payable and accrued expenses 3,609 79 476

Operating lease liability (1,261 ) 1,597 (340 )

Net Cash Provided by Operating Activities 11,421 5,177 11,621

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchase of property, plant and equipment (1,654 ) (5,095 ) (786 )

Cash paid for acquisition of the business of Crown I Enterprises, Inc., net (17,311 ) — —

Cash paid for acquisition/investment in Chef Inspirational Foods, LLC, net — — (646 )

Net Cash Used in Investing Activities (18,965 ) (5,095 ) (1,432 )

CASH FLOWS FROM FINANCING ACTIVITIES:

Net proceeds from the issuance of common stock 18,927 — —

Net proceeds from notes payable 18,770 — —

Repayments of debt (16,305 ) (1,662 ) (1,652 )

Repayment of line of credit, net — — (890 )

Repayment of term loan – related party (750 ) (1,950 ) (750 )

Repayment of finance lease obligations (345 ) (397 ) (272 )

Payment of Series B Preferred dividends — — (49 )

Proceeds from exercise of options 48 55 68

Net Cash Provided by (Used in) Financing Activities 20,345 (3,954 ) (3,545 )

Net Increase (Decrease) Increase in Cash 12,801 (3,872 ) 6,644

Cash and cash equivalents – Beginning of Period 7,150 11,022 4,378

Cash and cash equivalents – End of Period $ 19,951 $ 7,150 $ 11,022

SUPPLEMENTARY CASH FLOW INFORMATION:

Cash Paid During the Period for:

Income taxes $ 1,225 $ 1,477 $ 32

Interest $ 435 $ 654 $ 634

SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

Finance lease asset additions $ — $ 511 $ 1,270

Related party loan to finance acquisition $ — $ — $ 2,700

Right of use asset recognized $ 6,357 $ 2,119 $ —

Write-off of right of use asset $ 451 $ 1,021 $ —

Issuance of stock for director settlement $ — $ 450 $ —

Common stock issued for payment of related party debt $ 1,500 $ — $ —

Receipt of fixed assets for deposits previously paid $ — $ 937 $ —

Settlement of liability in common stock $ — $ — $ 50

Posted on April 14, 2026 4:10 pm
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif., April 14, 2026 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it granted an equity award in the form of a stock option to purchase 2,500,000 shares of Geron common stock to Timothy Williams, Geron’s new Executive Vice President, Chief Legal Officer and Corporate Secretary, as an inducement material to his acceptance of employment with Geron.

The stock option was granted on April 13, 2026. The stock option has an exercise price of $1.73 per share, which is equal to the closing price of Geron’s common stock on the grant date, has a ten-year term and vests over four years, with 12.5% of the shares underlying the option vesting on the six-month anniversary of commencement of his employment and the remaining shares vesting over the following 42 months in equal installments of whole shares, subject to continued service with Geron through the applicable vesting dates.

The stock option grant was approved by the Compensation Committee of Geron’s Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4) and is subject to the terms and conditions of Geron’s 2018 Inducement Award Plan and the form of stock option agreement under that plan.

About Geron

Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO^® (imetelstat) is approved in the United States and the European Union for the treatment of certain adult patients with lower-risk myelodysplastic syndromes with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis, as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit www.geron.com or follow us on LinkedIn.

CONTACT:

Dawn Schottlandt
Senior Vice President, Investor Relations and Corporate Affairs
[email protected]

Posted on April 14, 2026 4:10 pm
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation

Received FDA Fast Track Designation for pevifoscorvir sodium for the treatment of chronic hepatitis B virus infection

HBeAg- cohort sample size increased to optimize powering; futility criteria not met

Study drugs were well-tolerated by participants

Topline data expected in 2027, guidance remains unchanged

SOUTH SAN FRANCISCO, Calif., April 14, 2026 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced the first interim analysis results of the Phase 2 B-SUPREME study of pevifoscorvir sodium in participants with chronic hepatitis B virus (HBV) infection for the Part 2a (HBeAg- cohort) where the independent Data Safety Monitoring Review Board (DSMB) has recommended continuation of the study with an increase in sample size for this cohort in order to optimize statistical powering; futility criteria for the cohort was not met. Additionally, Aligos announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to pevifoscorvir sodium, a potential best/first-in-class capsid assembly modulator (CAM-E) under investigation for the treatment of chronic hepatitis B virus (HBV) infection.

Interim Analysis

The study design for the Phase 2 B-SUPREME study includes pre-specified sample size re-estimations for both Parts 1a and 2a to ensure sufficient power to demonstrate a statistically significant treatment effect at the primary endpoint. The first pre-specified interim analysis of the Phase 2 B-SUPREME study was performed after approximately 60% of HBeAg- participants (N=34, Part 2a) reached Week 12 or later. In addition, safety data was reviewed for all participants enrolled in the study (N=174) at the time the interim analysis was performed.

Findings from the first interim analysis include:

The DSMB recommended increasing the sample size of Part 2a from 74 currently enrolled to 100 participants. A futility analysis was performed; the prespecified futility criteria was not met, per the statistical analysis plan.

The study drugs were well-tolerated with no clinically concerning laboratory, physical examination, vital sign, or ECG abnormalities. No viral breakthrough related to study drugs has been observed in the study to date.

Aligos remains blinded to participant-level data. Completion of enrollment in the HBeAg- cohort is expected in the second half of 2026. Currently, there are 74 participants enrolled in the HBeAg- cohort (Part 2a), with 103 participants enrolled in the HBeAg+ cohort (Part 1a). Topline data remains on track for 2027.

“We are encouraged by this recommendation from the DSMB to increase the sample size in order to increase the probability for success of the study’s primary endpoint,” stated Lawrence Blatt, Ph.D., M.B.A., Chairman, President, and Chief Executive Officer at Aligos Therapeutics. “We believe we can enroll the necessary study participants in the coming months, with topline data on track for 2027. Additionally, I am thrilled to share that pevifoscorvir sodium has been granted Fast Track Designation. Aligos’ mission since its founding has been to improve outcomes for patients with unmet needs in liver and viral diseases and being granted Fast Track Designation for pevifoscorvir sodium is the next step in our journey to make this a reality. As we progress the Phase 2 B-SUPREME study, we look forward to working with regulators to determine the appropriate path forward.”

Fast Track Designation

The FDA Fast Track Designation was supported by the 96-Week Phase 1 (NCT04536337) data evaluating pevifoscorvir sodium monotherapy in patients with chronic HBV infection, which were presented at The Liver Meeting® 2025, along with the 8-Week nucleoside analog follow-up data. This study demonstrated that pevifoscorvir sodium was well tolerated by study participants and the data demonstrated potential best-in-class reductions across clinically relevant viral markers.

Fast Track Designation is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. It enables more frequent meetings and communication with the FDA to ensure alignment on development plans and the collection of clinical data needed to support approval. Furthermore, clinical programs with Fast Track Designation may be eligible for Rolling Review, Accelerated Approval and Priority Review if relevant criteria are met. For conditions where an available treatment exists, a drug candidate must show some advantage over available therapy, such as superior effectiveness, to be granted Fast Track Designation¹.

About B-SUPREME

The Phase 2 B-SUPREME study (NCT06963710) is a randomized, double-blind, active-controlled multicenter study evaluating the safety and efficacy of pevifoscorvir sodium monotherapy compared with tenofovir disoproxil fumarate in approximately 200 untreated HBeAg+ and HBeAg- adult subjects with chronic HBV infection for 48 weeks. The primary endpoint in the HBeAg+ part is HBV DNA <LLOQ (10 IU/mL, target detected [TD] or target not detected [TND]) and the primary endpoint in the HBeAg- part is HBV DNA <LLOQ (10 IU/mL, target not detected [TND]). The study will also evaluate the safety, pharmacokinetics, and other secondary and exploratory biomarkers, including reductions in HBV antigens and other markers of HBV infection. The second interim analysis is expected in the second half of 2026 and topline data is expected in 2027.

About pevifoscorvir sodium

Pevifoscorvir sodium (formerly known as ALG-000184) was derived from initial IP licensed from the laboratory of Dr. Raymond Schinazi at Emory University, which was further optimized by Aligos. Pevifoscorvir sodium is a potent potential best/first-in-class oral small molecule capsid assembly modulator (CAM-E) being developed for chronic hepatitis B virus (HBV) infection. Phase 1 studies have demonstrated after single and multiple daily doses that pevifoscorvir sodium was well-tolerated by study participants, with no safety signals observed, and demonstrated linear PK and promising antiviral activity. In longer term Phase 1 studies, pevifoscorvir sodium 300mg QD x ≤96 weeks monotherapy has demonstrated sustained reductions in HBV DNA, RNA, HBsAg, HBeAg, and HBcrAg. Pevifoscorvir sodium has a regulatory path, as acknowledged by the FDA, EMA, and NMPA (China), for subsequent studies utilizing the chronic suppressive pathway.

About Chronic HBV Infection

Chronic hepatitis B virus (HBV) infection is a life-threatening viral infection that primarily affects the liver with 254 million patients worldwide and approximately 1.2 million individuals become newly infected every year despite the availability of a prophylactic vaccine. Complications include cirrhosis, end-stage liver disease, and hepatocellular carcinoma, which collectively resulted in approximately 1.08 million deaths in 2022, according to the European Association for the Study of the Liver’s 2025 clinical practice guidelines. Chronic HBV infection is the primary cause of liver cancer worldwide, and the mortality associated with HBV-related liver cancer continues to increase.

About Aligos

Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a clinical stage biopharmaceutical company founded with the mission to improve patient outcomes by developing best-in-class therapies for the treatment of liver and viral diseases. Aligos applies its science driven approach and deep R&D expertise to advance its purpose-built pipeline of therapeutics with high unmet medical needs such as chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronaviruses.

For more information, please visit www.aligos.com or follow us on LinkedIn or X.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release that are not historical facts may be considered “forward-looking statements,” including without limitation, statements regarding Aligos’ mission to improve patient outcomes by developing best-in-class therapies for the treatment of liver and viral diseases; the expected pace of enrollment in the B-SUPREME study, timing for enrollment completion, expectations for second interim analysis in the second half of 2026, and expectations for topline data in 2027; whether the planned increase in enrollment will lead to success in meeting the study’s primary endpoint; expectations regarding what the B-SUPREME study will evaluate in the future; and whether the granting of Fast Track Designation by the FDA for pevifoscorvir sodium will lead to improved outcomes for patients with unmet needs in liver and viral diseases. Such forward-looking statements are subject to substantial risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties inherent in the drug development process, including Aligos’ clinical stage of development, the process of designing and conducting clinical trials and the regulatory approval processes. For a further description of the risks and uncertainties that could cause actual results to differ from those anticipated in these forward-looking statements, as well as risks relating to the business of Aligos in general, see Aligos’ Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 5, 2026 and its future periodic reports to be filed or submitted with the Securities and Exchange Commission. Except as required by law, Aligos undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances, or to reflect the occurrence of unanticipated events.

https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/fast-track (Accessed April 14, 2026)

Aligos Therapeutics

Contact

Jordyn Tarazi
Vice President, Investor Relations & Corporate Communications
+1 (650) 910-0427
[email protected]

Media Contact

Inizio Evoke
Jake Robison
Vice President
[email protected]

Posted on April 14, 2026 4:10 pm
Cricut to Announce First Quarter 2026 Financial Results on May 5, 2026

SOUTH JORDAN, Utah, April 14, 2026 (GLOBE NEWSWIRE) — Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced it will report its financial results for the first quarter ended March 31, 2026 after the U.S. markets close on Tuesday, May 5, 2026. Cricut management will host a conference call and webcast to discuss the results that afternoon at 3:00 p.m. Mountain Time (5:00 p.m. Eastern Time).

A live webcast of the earnings call will be available on Cricut’s investor relations website at https://investor.cricut.com/. A webcast replay will be available after the live event.

To access the audio call, please pre-register using this link: Cricut Q1 2026 Earnings Pre-Registration. After registering, a confirmation will be sent via email and will include dial-in details and a unique PIN code for entry to the call. To avoid long wait times, we suggest registering at least one day in advance or at minimum 15 minutes before the start of the call to receive your unique PIN code.

About Cricut, Inc.

Cricut, Inc. is a creative platform company that makes it easy for users to create meaningful personal items. Cricut hardware and software work together as a connected platform for consumers to make beautiful, high-quality projects quickly and easily. These industry-leading products include a flagship line of smart cutting machines — the Cricut Maker^® family, the Cricut Explore^® family, and the Cricut Joy^® family — accompanied by other unique tools like Cricut EasyPress^®, the Infusible Ink™ system, and a diverse collection of materials. In addition to providing tools and materials, Cricut fosters a thriving community of millions of dedicated users worldwide.

Cricut has used, and intends to continue using, its investor relations website and the Cricut News Blog (https://inspiration.cricut.com) to disclose material non-public information and to comply with its disclosure obligations under Regulation FD. Accordingly, you should monitor our investor relations website and the Cricut News Blog in addition to following our press releases, SEC filings and public conference calls and webcasts.

Contacts:

Press
[email protected]

Investor Relations
[email protected]

Source: Cricut, Inc.

Posts pagination

Page 1 Page 2 … Page 42,203 Next page